Search results
Found 62 matches for
The first ever Orthopaedic Surgical Trials Day was held at the Royal College of Surgeons (RCS) this March. The objective of the day was to bring together the orthopaedic surgical research community to present current trials, intended projects and discuss issues that affect surgical trial research in this area.
Simon Matthew Graham awarded an MRC Clinician Scientist Fellowship
Botnar Funding Main Orthopaedics and trauma
26 March 2024
The award from the Medical Research Council (MRC) will support research to improve treatments for open fractures in low- and middle-income countries.
CRUK funding success for Audrey Gérard
Funding Kennedy Main
14 February 2024
Audrey Gérard has received £ 1.5 million in funding from CRUK for a new research project to unravel the coevolving cancer and immune landscape.
Data-Driven research will map COVID-19 vaccine effectiveness in Brazil and Pakistan
Funding Main Statistics and epidemiology
5 April 2023
A study to monitor the safety and effectiveness of the COVID-19 vaccine in the Global South, has received funding from the Bill & Melinda Gates Foundation’s Grand Challenges initiative.
NIHR funding for musculoskeletal and inflammatory disease research
Department Funding Kennedy Orthopaedics and trauma Trauma
17 October 2022
Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients.
MRC funding awarded to Kennedy researchers
Funding Inflammation biology Kennedy Main
8 September 2022
Two new projects led by Tal Arnon and Irina Udalova have been awarded Medical Research Council (MRC) funding.
Oxford receives NIHR funding to test anti-TNF on post operative delirium
Funding Hip Main OCTRU Orthopaedics and trauma Trauma
27 July 2022
Researchers at the University of Oxford have been awarded a grant from the National Institute for Health and Care Research (NIHR) to investigate whether anti-tumour necrosis factor (TNF) therapy can reduce or prevent post operative delirium/cognitive deficit.
Kennedy researchers awarded funding to improve the understanding of inflammatory bowel diseases
Funding Kennedy Main
5 July 2022
A new £1.5M grant from the Medical Research Council (MRC) to the Powrie Group at the Kennedy Institute will help define different pathotypes of inflammatory bowel diseases that could lead to better and more focused treatments for patients.
Oxford researchers awarded funding to study the immune response to malaria
Funding Kennedy Main
15 March 2022
Professors Matthew Higgins and Michael Dustin from the University of Oxford, Prof Gavin Wright from the University of York, and Professors Shiroh Iwanaga and Hisashi Arase from Osaka University have secured a Wellcome Collaborative Award for their study “How do RIFINs and STEVORs modulate human immunity during malaria?”
Funding boost for early-stage clinical research
Funding Main
8 March 2022
Oxford is one of 28 sites that will benefit from over £160 million awarded over five years to expand early phase clinical research for the benefit of NHS patients.
New funding awarded to study persistent pain in inflammatory arthritis
Arthritis Funding Kennedy Main
7 March 2022
The £3.9M Wellcome Collaborative Award will be used to identify the drivers of pain in people living with rheumatoid arthritis.
Single-cell ancestry vaccine research funded by the Chan Zuckerberg Initiative
Funding Kennedy Main
17 November 2021
The Chan Zuckerberg Initiative (CZI) has provided $2 million in funding to investigate how our ancestry and diversity influence the way that vaccines work in our cells.
Chan Zuckerberg Initiative funding awarded to build a globally inclusive musculoskeletal map
Funding Main
12 November 2021
NDORMS researchers and several international collaborators have been awarded funding from the Chan Zuckerberg Initiative to deliver an ancestrally diverse musculoskeletal atlas of healthy tissues.
New advanced analytics research to deliver next level of insights into COVID-19
CSM Coronavirus COVID-19 Funding Main Statistics and epidemiology
11 November 2021
NDORMS is leading one of nine new studies awarded total of £2m to use large-scale linked data to address priority research questions that will improve understanding of the pandemic and inform the continued policy response.
NDORMS researchers awarded funding by The Paget’s Association
Awards Funding Main
19 October 2021
Professor Philippa Hulley and Doctor Helen Knowles have been awarded funding by The Paget’s Association for their research on bone cells.
NDORMS researchers awarded NIHR Fellowships
Awards Funding Main Trauma
19 October 2021
Six researchers from the Botnar Research Centre have been awarded NIHR (National Institute for Health Research) Fellowships.
Novo Nordisk Postdoctoral Research Fellowship awarded to Inhye Park
Funding Kennedy
6 October 2021
Inhye Park has been awarded a Novo Nordisk Postdoctoral Research Fellowship to research the biology of resident vascular macrophages in atherosclerosis.
NDORMS joins research partnership to understand links between overlapping long-term conditions
Botnar Funding Main
23 July 2021
The links between different long-term health conditions will be explored in new research funded with a £2.5million grant from the Medical Research Council.
NDORMS researchers awarded grant for study on the effects of COVID-19 vaccines on long COVID
Coronavirus COVID-19 Funding
19 July 2021
A team of NDORMS researchers including Doctor Annika Jödicke and Doctor Victoria Strauss have been awarded NIHR funding to carry out a study into the effects of different COVID-19 vaccines on long COVID.
New research could improve quality of life for Psoriatic Arthritis patients
Arthritis Botnar Coronavirus COVID-19 Funding Main
2 July 2021
Professors Laura Coates and Dani Prieto-Alhambra will take major roles in a new European Commission project to develop innovative personalised treatment options for people affected by psoriatic arthritis.
A more tailored approach to treating psoriatic arthritis
Arthritis Botnar Funding Main
8 January 2021
Dr Laura Coates has been awarded £1.8M from the National Institute for Health Research (NIHR) to explore the potential for precision medicine in the choice of biologics to reduce inflammation and pain in psoriatic arthritis.